BACKGROUND Early detection has increased prostate cancer (PCa) incidence.
Randomized trials have demonstrated that early detection reduces the incidence of de novo …

Background The diagnostic characteristics of men who eventually die from prostate cancer
(PCa) and the extent to which early diagnostic strategies have affected these characteristics …

Introduction During recent years, several new life-prolonging therapeutic options have been
introduced for patients with metastatic prostate cancer (mPCa). The aim of the present study …

Objective Several therapies for localised prostate cancer (PC) are available; all yield similar
survival rates. However, each therapy has significant side effects that can influence patients' …

The overall aging of the world population has contributed to the continuous upward trend in
the incidence of prostate cancer (PC). Trials on PC therapy have been extensively …

Background Prostate cancer is the most common malignant tumor of male genitourinary
system, molecular mechanism of which is still not clear. PSMC2 (proteasome 26S subunit …

Introduction Androgen deprivation therapy (ADT) is a mainstay of treatment against
advanced prostate cancer (PC). As a treatment goal, suppression of plasma testosterone …

Men with high‐grade prostate cancer (HGPC) are at greatest risk of disease progression.
Clinical risk factors associated with castration‐resistant prostate cancer (CRPC) …

Introducción: El presente artículo resume la guía de práctica clínica (GPC) para el tamizaje,
diagnóstico, y tratamiento inicial del cáncer de próstata localizado y localmente avanzado …

Purpose Prostatectomy, radiotherapy and watchful waiting are the main therapeutic options
available for local stage of prostate cancer (PCa). We report our experience on 394 patients …